Verrica Pharmaceuticals Inc (VRCA): Next-Year EPS Estimate 41.61%
As of 2026-06-04, Verrica Pharmaceuticals Inc (VRCA) has a next-year EPS growth estimate of 41.61%.
VRCA was first flagged by our screen on 2026-05-26, when analyst consensus for its next-year EPS growth was revised from 40.60% to 41.61%. Current-year growth is projected at 5.95%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 41.61%
- EPS growth this year
- 5.95%
- EPS next quarter (est)
- -$0.41
- Last price
- $6.15
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 41.61% | 5.95% | -$0.41 | $6.15 |
| 2026-06-03 | 41.61% | 5.95% | -$0.41 | $5.87 |
| 2026-06-02 | 41.61% | 5.95% | -$0.41 | $5.79 |
| 2026-06-01 | 41.61% | 5.95% | -$0.41 | $5.90 |
| 2026-05-31 | 41.61% | 5.95% | -$0.41 | $5.76 |
| 2026-05-28 | 41.61% | 5.95% | -$0.41 | $6.03 |
| 2026-05-27 | 41.61% | 5.95% | -$0.41 | $6.06 |
| 2026-05-26 | 41.61% | 5.95% | -$0.41 | $6.02 |
| 2026-05-25 | 40.60% | 5.80% | -$0.41 | $6.06 |
| 2026-05-24 | 40.60% | 5.80% | -$0.41 | $6.06 |
| 2026-05-21 | 40.60% | 5.80% | -$0.41 | $5.90 |
| 2026-05-20 | 40.60% | 5.80% | -$0.41 | $6.02 |
| 2026-05-19 | 40.60% | 5.80% | -$0.41 | $5.59 |
| 2026-05-18 | 40.60% | 5.80% | -$0.41 | $5.87 |
| 2026-05-17 | 40.60% | 5.80% | -$0.41 | $6.27 |
| 2026-05-14 | 40.60% | 5.80% | -$0.41 | $6.95 |
| 2026-05-13 | 40.60% | 5.80% | -$0.41 | $7.91 |
| 2026-05-12 | 48.29% | 14.04% | -$0.45 | $7.15 |
| 2026-05-11 | 48.29% | 14.04% | -$0.45 | $7.40 |
| 2026-05-10 | 48.29% | 14.04% | -$0.45 | $7.99 |
| 2026-05-07 | 48.29% | 14.04% | -$0.45 | $8.24 |
| 2026-05-06 | 48.29% | 14.04% | -$0.45 | $8.43 |
| 2026-05-05 | 48.29% | 14.04% | -$0.45 | $7.16 |
| 2026-05-04 | 48.29% | 14.04% | -$0.45 | $6.36 |
| 2026-05-03 | 48.29% | 14.04% | -$0.45 | $6.27 |
| 2026-04-30 | 48.29% | 14.04% | -$0.45 | $6.37 |
| 2026-04-29 | 48.29% | 14.04% | -$0.45 | $6.58 |
| 2026-04-28 | 48.29% | 14.04% | -$0.45 | $6.53 |
| 2026-04-27 | 48.29% | 14.04% | -$0.45 | $6.82 |
| 2026-04-26 | 48.29% | 14.04% | -$0.45 | $6.98 |
Recent News
- Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQGlobeNewswire
- Verrica Pharmaceuticals Inc (VRCA) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...GuruFocus.com
- Verrica Pharmaceuticals Reports First Quarter 2026 Financial ResultsGlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Verrica Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Verrica Pharmaceuticals Inc (VRCA) has a next-year EPS growth estimate of 41.61%, based on analyst consensus.
When was the latest EPS estimate revision for VRCA?▾
The most recent revision occurred on 2026-05-26, when analysts adjusted the next-year EPS growth estimate from 40.60% to 41.61%.
What sector and industry does Verrica Pharmaceuticals Inc belong to?▾
Verrica Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. VRCA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Verrica Pharmaceuticals Inc (VRCA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports